Blood Culture Tests Market size was valued at USD 6.64 billion in 2024 and is projected to exceed USD 28.31 billion by the end of 2037, expanding at over 11.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of blood culture tests is evaluated at USD 7.27 billion. Nosocomial infections are a major problem that requires global attention. A group of infections called HAIs are infections that the patient did not have before being admitted to the hospital. HAIs occur when a patient arrives at the hospital or 48 to 72 hours after admission. It doesn't even exist during waiting time. Currently, these diseases have become a serious problem for both medical institutions and the public, requiring increased medication and testing, prolonging treatment periods, and placing an unnecessary financial burden on patients and medical institutions. As a result, the demand for blood culture testing to investigate infectious diseases and the demand for blood culture testing market is increasing. According to a study by the Centers for Disease Control and Prevention, about 1 in 31 hospitalized patients in the United States suffers from a healthcare-associated infection.
Antibiotics are drugs used to prevent and treat infectious diseases in humans, animals, and plants. These include antibiotics, antiviral drugs, antifungal drugs, and antiparasitic drugs. Antibiotics and other antimicrobial drugs lose their effectiveness due to drug resistance, making infections difficult or impossible to treat and increasing the risk of disease transmission, serious illness, disability, and death. Blood culture tests are primarily used to detect microbial resistance. Most of the bacteria isolated from blood cultures were found to be multidrug-resistant, especially to first- and second-line antibiotics. Thus, growing cases of antimicrobial resistance are set to drive market growth in the upcoming period.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
11.8% |
|
Base Year Market Size (2024) |
USD 6.64 billion |
|
Forecast Year Market Size (2037) |
USD 28.31 billion |
|
Regional Scope |
|
Analysis (Phenotypic AST, Genotypic AST)
The phenotypic AST segment share in the blood culture tests market is anticipated to surpass 72% by 2037. The growth of this segment is due to the increased demand for blood culture tests with a view to determining whether or not antibiotics are effective in preventing bacteria, thus providing physicians with vital information on appropriate antibiotic treatment options. The demand for phenotypic AST is also increasing due to an increased incidence of conditions such as sepsis. For example, sepsis is a potentially fatal disease that occurs when the body's response to an infection causes tissue and organ damage as defined by WHO. Although it is difficult to determine the true global epidemiological burden of sepsis, recent scientific papers estimate that an estimated 49 million people worldwide suffer from sepsis each year, and a total of 11 million people die from sepsis.
Test Type (Current Routine Test, Rapid Test)
Blood culture tests market from the current routine test segment is predicted to hold the largest share of 64% during the forecast period. One of the most important methods to monitor overall physical well-being is regular blood tests or a culture test. It may be able to understand the body changes over time and allow it to make informed decisions about health by being tested regularly. In order to diagnose infections and control the presence of germs in the blood, blood culture testing is commonly used.
Our in-depth analysis of the global blood culture tests market includes the following segments:
|
Test Type |
|
|
Analysis |
|
|
Product |
|
|
Method |
|
|
Technology |
|
|
Application |
|
|
End User |
|
APAC Market Forecast
The blood culture tests market share in Asia Pacific is estimated to cross more than 33% by 2037. Blood culture is currently the accepted method of diagnosis for possible bacteremia in the region. If bacteremia is suspected in a majority of high-income countries, blood cultures are often provided to patients with fever. Nevertheless, when working under resource constraints, physicians may decide to give patients direct treatment due to a lack of or limited laboratory capacities. In the present era of increasing antibiotic resistance, particularly in South Asia, blood cultures are becoming a more important tool to help identify the best course of therapy and promote effective management.
North American Market Statistics
The blood culture tests market in the North American region is set to grow substantially by reaching 31% share by the end of 2037. Rising demand for antimicrobial susceptibility testing awaits the blood culture testing market in the region. The most effective treatment for patients with bloodstream infections depends largely on the rapid identification of blood culture isolates and the conclusions of his AST. The importance of blood cultures is highlighted in the area by the fact that empiric antibiotic dosing is often inappropriate, leading to increased morbidity and mortality, prolonged hospital stays, and associated healthcare costs. Additionally, in September 2023, FDA issued a regulation entitled “Antibiotic Susceptibility Testing System Devices – Updates to Breakpoints in Device Labeling,” effective immediately.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?